Revision history of "ERDF — CLCC Baclesse — CIER ToxiP3" (Q3680268)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

20 March 2024

7 December 2023

12 June 2023

18 July 2022

  • curprev 12:0112:01, 18 July 2022DG Regio talk contribs 100,239 bytes +70,806 Changed label, description and/or aliases in da, el, hr, ro, sk, mt, pt, fi, pl, sl, cs, lt, lv, bg, hu, ga, sv, et, nl, fr, de, it, es, and other parts: Adding translations: da, el, hr, ro, sk, mt, pt, fi, pl, sl, cs, lt, lv, bg, hu, ga, sv, et,

14 January 2022

13 January 2022

6 December 2021

1 December 2021

  • curprev 08:1408:14, 1 December 2021DG Regio talk contribs 18,200 bytes +3,672 Created claim: summary (P836): Im Rahmen der Entwicklung des Archade-Zentrums in Caen mit der Einführung der ersten Protonentherapie bieten wir eine Studie über die Nebenwirkungen innovativer Protonenbehandlungen in Kombination mit einem radiosensibilisierenden Mittel an, das die DNA-Reparatur einschränkt: das Projekt ToxIP3. Das Projekt zielt daher darauf ab, die Toxizität in gesunden Geweben von Olaparib, einer inhibitorischen Behandlung von PARP (Poly(ADP-Ribose)-Polymeras...

27 November 2021

  • curprev 12:5612:56, 27 November 2021DG Regio talk contribs 14,528 bytes −3,769 Removed claim: summary (P836): Dans le cadre du développement du centre archade à Caen avec la mise en place des premiers traitements par protonthérapie, nous proposons une étude des effets secondaires de traitements innovants par protons combinés avec un agent radiosensibilisant limitant la réparation de l’ADN: Le projet ToxIP3. CE projet vise donc à évaluer la toxicité dans les tissus sains de l’olaparib, un traitement inhibiteur de PARP (Poly(ADP-ribose) polymérases), en...

26 November 2021

  • curprev 23:1823:18, 26 November 2021DG Regio talk contribs 18,297 bytes +3,769 Created claim: summary (P836): Dans le cadre du développement du centre archade à Caen avec la mise en place des premiers traitements par protonthérapie, nous proposons une étude des effets secondaires de traitements innovants par protons combinés avec un agent radiosensibilisant limitant la réparation de l’ADN: Le projet ToxIP3. CE projet vise donc à évaluer la toxicité dans les tissus sains de l’olaparib, un traitement inhibiteur de PARP (Poly(ADP-ribose) polymérases), en c...
  • curprev 14:5314:53, 26 November 2021DG Regio talk contribs 14,528 bytes +98 Changed label, description and/or aliases in de: translated_label

24 November 2021

22 November 2021

18 November 2021

  • curprev 17:0017:00, 18 November 2021DG Regio talk contribs 13,566 bytes +97 Changed label, description and/or aliases in en: translated_label
  • curprev 17:0017:00, 18 November 2021DG Regio talk contribs 13,469 bytes +3,397 Created claim: summary (P836): As part of the development of the archade centre in Caen with the implementation of the first proton therapy treatments, we propose a study of the side effects of innovative proton treatments combined with a radiosensitising agent limiting DNA repair: the ToxIP3 project. The aim of this project is to assess the toxicity in healthy tissues of olaparib, an inhibitory treatment of PARP (poly(ADP-ribose) polymerases), in combination with proton ther...
  • curprev 09:4409:44, 18 November 2021DG Regio talk contribs 10,072 bytes +508 Changed an Item: Edited by the infer coords bot - inferring coordiantes from postal codes

17 November 2021